Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Inflammation Associated With Obesity, Aging, and Amyloid Burden in Adults With Down Syndrome.

Obesity (Silver Spring, Md.)·2026

Same author

An X-linked long non-coding RNA, PTCHD1-AS, and the core features of autism.

Nature·2026

Same author

Circadian Rest-Activity Rhythms, Cognition, and Alzheimer Disease Dementia in Adults With Down Syndrome.

Neurology·2026

Same author

Use of implementation science models, theories, and frameworks in pediatric rehabilitation: Protocol for a scoping review.

PloS one·2026

Same author

Socio-Demographic Associations and Frequencies of Physical Activity Participation of Autistic Adolescents Reported by Parents in Ontario, Canada.

Journal of autism and developmental disorders·2026

Same author

An n-of-1 gene-directed drug repurposing trial for an ultrarare genetic condition.

Epilepsia·2026

Same journal

Preventing Child Abuse Through a Brief Parenting Intervention: 2.5 Year Outcomes From the Safer Kids Randomized Controlled Trial.

Journal of the American Academy of Child and Adolescent Psychiatry·2026

Same journal

Reducing Unnecessary Medical Screening for Pediatric Psychiatric Admissions in the Emergency Department: A Quality Improvement Approach to Implementing Choosing Wisely Recommendations.

Journal of the American Academy of Child and Adolescent Psychiatry·2026

Same journal

Aberrant Brain Topological Properties in Early-Onset and Adult-Onset Schizophrenia: Evidence from First-Episode Drug-Naïve and Medicated Groups.

Journal of the American Academy of Child and Adolescent Psychiatry·2026

Same journal

Data-Driven Profiles of Youth Executive Function and Their Longitudinal Associations With Externalizing Problems.

Journal of the American Academy of Child and Adolescent Psychiatry·2026

Same journal

Systematic Review and Meta-Analysis: Prevalence, Correlates, and Impact of Cannabis Use and Cannabis Use Disorder in Early-Onset Psychosis.

Journal of the American Academy of Child and Adolescent Psychiatry·2026

Same journal

Discontinuation, Medication Switching, and Augmentation After SSRI in Pediatric Depression.

Journal of the American Academy of Child and Adolescent Psychiatry·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Feb 4, 2026

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

Dr. Handen et al. Reply.

Benjamin L Handen¹, Jeremy Veenstra-VanderWeele², Evdokia Anagnostou³

¹Western Psychiatric Institute and Clinic of the University of Pittsburg Medical Center, PA.

Journal of the American Academy of Child and Adolescent Psychiatry

|October 3, 2018

Summary

This summary is machine-generated.

Metformin may help manage weight gain in children with autism spectrum disorder (ASD) on antipsychotics. Further research is needed to confirm its effectiveness and identify patient subgroups who benefit most.

More Related Videos

Quaternary Structure Modeling Through Chemical Cross-Linking Mass Spectrometry: Extending TX-MS Jupyter Reports

Quaternary Structure Modeling Through Chemical Cross-Linking Mass Spectrometry: Extending TX-MS Jupyter Reports

Published on: October 20, 2021

Direct Restart of a Replication Fork Stalled by a Head-On RNA Polymerase

Direct Restart of a Replication Fork Stalled by a Head-On RNA Polymerase

Published on: April 29, 2010

Related Experiment Videos

Last Updated: Feb 4, 2026

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix

Published on: October 20, 2021

Quaternary Structure Modeling Through Chemical Cross-Linking Mass Spectrometry: Extending TX-MS Jupyter Reports

Quaternary Structure Modeling Through Chemical Cross-Linking Mass Spectrometry: Extending TX-MS Jupyter Reports

Published on: October 20, 2021

Direct Restart of a Replication Fork Stalled by a Head-On RNA Polymerase

Direct Restart of a Replication Fork Stalled by a Head-On RNA Polymerase

Published on: April 29, 2010

Area of Science:

Pediatric Endocrinology
Neurodevelopmental Disorders
Pharmacological Interventions

Background:

Discusses a prior study on metformin's efficacy in managing weight gain associated with second-generation antipsychotic (SGA) use in children with autism spectrum disorder (ASD).
Addresses commentary regarding the premature conclusion of recommending metformin as an adjunct treatment for overweight children with ASD on SGAs.
Highlights the ongoing MOBILITY study, a pragmatic clinical trial investigating metformin's effectiveness in conjunction with lifestyle interventions.

Discussion:

Examines the debate surrounding the adjunct use of metformin for weight management in pediatric ASD patients prescribed SGAs.
Considers the recommendation for results from the MOBILITY study to inform clinical decisions regarding metformin prescription.
Emphasizes the need for identifying moderators and mediators of metformin's effects to guide personalized treatment strategies.

Key Insights:

Initial findings suggest metformin may be beneficial for weight management in children with ASD on SGAs.
The MOBILITY study aims to provide crucial data on the comparative effectiveness of metformin plus lifestyle changes versus lifestyle changes alone.
Identifying patient-specific factors influencing metformin response is essential for optimizing its clinical application.

Outlook:

Further pragmatic trials are necessary to establish definitive guidelines for metformin use in pediatric ASD.
Future research should focus on elucidating the mechanisms underlying metformin's effects in this population.
Personalized treatment approaches integrating pharmacological and lifestyle interventions hold promise for managing weight-related comorbidities in ASD.